Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ
Huilian Hou, Wei Chen, Le Zhao, Qinqin Zuo, Guanjun Zhang, Xuebin Zhang, Hongyan Wang, Huilin Gong, Xiaofeng Li, Min Wang, Yili Wang, Xu Li
Journal of Clinical Pathology Dec 2012, 65 (12) 1088-1096; DOI: 10.1136/jclinpath-2012-200940
